Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Telomeres, the nucleoprotein complex at the ends of eukaryotic chromosomes, perform an essential cellular role in part by preventing the chromosomal end from initiating a DNA-damage response. This function of telomeres can be compromised as telomeres erode either as a consequence of cell division in culture or as a normal part of cellular ageing in proliferative tissues. Telomere dysfunction in this context leads to DNA-damage signaling and activation of the tumor-suppressor protein p53, which then can prompt either cellular senescence or apoptosis. By culling cells with dysfunctional telomeres, p53 plays a critical role in protecting tissues against the effects of critically short telomeres. However, as telomere dysfunction worsens, p53 likely exacerbates short telomere-driven tissue failure diseases, including pulmonary fibrosis, aplastic anemia, and liver cirrhosis. In cells lacking p53, unchecked telomere shortening drives chromosomal end-to-end fusions and cycles of chromosome fusion-bridge-breakage. Incipient cancer cells confronting these telomere barriers must disable p53 signaling to avoid senescence and eventually up-regulate telomerase to achieve cellular immortality. The recent findings of highly recurrent activating mutations in the promoter for the telomerase reverse transcriptase (TERT) gene in diverse human cancers, together with the widespread mutations in p53 in cancer, provide support for the idea that circumvention of a telomere-p53 checkpoint is essential for malignant progression in human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 2×
“…TRF2 through overexpression of a dominantnegative form or through deletion in TRF2 knockout mouse embryo fibroblasts leads to loss of the protective capped structure, characterized by processing of the 30 overhang and ligation of chromosome ends (van Steensel et al. 1998; Celli and de Lange 2005).”
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Senescent human fibroblasts show a number of telomeric foci that contain phosphorylated H2AX and 53BP1, hallmarks of double-stranded breaks (d’Adda di Fagagna et al. 2003; Takai et al. 2003).”
BackgroundMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 3×
“The single-stranded overhang can fold back on the double-stranded telomere in a lariat structure termed the T-loop, which serves to sequester the chromosome terminus, which hybridizes to internal sequences creating a small displacement loop, or D-loop (Griffith et al. 1999; Doksani et al. 2013).”
BackgroundTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 1×
“Rather than cell-cycle arrest, crisis is characterized by high rates of cell death and rampant chromosomal instability, including endto-end chromosome fusions (Counter et al. 1992).”
BackgroundOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 1×
“Recent findings show that many human cancer types show highly recurrent mutations in the TERT promoter (Horn et al. 2013; Huang et al. 2013).”
BackgroundMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
TRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709 · cited 1×
“…TRF2 through overexpression of a dominantnegative form or through deletion in TRF2 knockout mouse embryo fibroblasts leads to loss of the protective capped structure, characterized by processing of the 30 overhang and ligation of chromosome ends (van Steensel et al. 1998; Celli and de Lange 2005).”
BackgroundWATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Telomerase mutations underlie approximately 20% of familial idiopathic pulmonary fibrosis (Armanios et al. 2007).”
BackgroundLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 2×
“Telomere shortening in G6 TERC p53þ/þ mice precipitated a premature aging phenotype, characterized by kyphosis, hair graying, hair loss, villous atrophy in the intestine, and impaired systemic stress responses (Herrera et al. 1999; Rudolph et al. 1999).”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“Most prominent among the phenotypes were infertility and loss of the male germline, intestinal dysfunction, and lymphocyte dysfunction (Lee et al. 1998; Wong et al. 2000).”
BackgroundControl of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219
Pot1, the Putative Telomere End-Binding Protein in Fission Yeast and Humans
Baumann, P., & Cech, T. R. (2001) · Science · doi:10.1126/science.1060036 · Cited by 1,028
Blackburn, E. H., & Gall, J. G. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90294-2 · Cited by 1,023
Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication
Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., & de Lange, T. (2009) · Cell · doi:10.1016/j.cell.2009.06.021 · Cited by 990
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 2×
“Late-generation TERC mice showed very high levels of apoptosis in multiple organs, including testis, lymphoid tissue, and intestinal epithelium, coincident with stabilization and activation of p53 (Chin et al. 1999).”
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 2×
“Mutations in the catalytic core of the enzyme, TERTor TERC, typically occur in one allele and act through haploinsufficiency to reduce enzyme activity (Vulliamy et al. 2001; Armanios et al. 2005; Yamaguchi et al. 2005).”
BackgroundAn alternative pathway for yeast telomere maintenance rescues est1− senescence
Lundblad, V., & Blackburn, E. H. (1993) · Cell · doi:10.1016/0092-8674(93)90234-h · Cited by 942 · cited 1×
“In Tetrahymena or in S. cerevisiae, interfering with telomerase function triggered senescence in these organisms, providing a key mechanistic link between telomeres and senescence in unicellulareukaryotes (Yu et al. 1990; Lundblad and Blackburn 1993).”
BackgroundProtection of telomeres through independent control of ATM and ATR by TRF2 and POT1
Denchi, E. L., & de Lange, T. (2007) · Nature · doi:10.1038/nature06065 · Cited by 880
Control of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768 · cited 1×
“TRF1 can act to modulate telomere length, but it serves a critical role in facilitating DNA replication through the telomere repeats, which act as fragile DNA sites (van Steensel and de Lange 1997; Smogorzewska et al. 2000; Martinez et al. 2009; Sfeir et al. 2009).”
BackgroundA role for both RB and p53 in the regulation of human cellular senescence*1
SHAY, J. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90453-2 · Cited by 757
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
The POT1-TPP1 telomere complex is a telomerase processivity factor.
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R., & Lei, M. (2007) · Nature · doi:10.1038/nature05454 · Cited by 704
Yu, G.-L., Bradley, J. D., Attardi, L. D., & Blackburn, E. H. (1990) · Nature · doi:10.1038/344126a0 · Cited by 632 · cited 2×
“In Tetrahymena or in S. cerevisiae, interfering with telomerase function triggered senescence in these organisms, providing a key mechanistic link between telomeres and senescence in unicellulareukaryotes (Yu et al. 1990; Lundblad and Blackburn 1993).”
BackgroundDNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
Celli, G. B., & de Lange, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1275 · Cited by 623
Hypervariable ultra-long telomeres in mice
Kipling, D., & Cooke, H. J. (1990) · Nature · doi:10.1038/347400a0 · Cited by 614
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566 · cited 2×
“Binding of GABPA to the mutant, but not the wild-type TERT promoter can activate TERT expression.”
BackgroundPlasma antioxidants from chocolate
Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., & Crozier, A. (2003) · Nature · doi:10.1038/4241013a · Cited by 539
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“Interestingly, adenomas from these mice showed overexpression of p53 and an Cite this article as Cold Spring Harb Perspect Med 2017;7:a026088 7 w w w .p er sp ec ti ve si n m ed ic in e. o rg increased amount of apoptosis (Rudolph et al. 2001).”
BackgroundTIN2, a new regulator of telomere length in human cells
Kim, S.-H., Kaminker, P., & Campisi, J. (1999) · Nature Genetics · doi:10.1038/70508 · Cited by 525 · cited 8×
“TIN2 also interacts with the subcomplex of shelterin that binds the singlestranded overhang: TPP1 and POT1, two oligosaccharide-binding (OB)-fold-containing proteins (Baumann and Cech 2001; Liu et al. 2004; Ye et al. 2004).”
BackgroundInfluentialA Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis
Venteicher, A. S., Abreu, E. B., Meng, Z., McCann, K. E., Terns, R. M., Veenstra, T. D., Terns, M. P., & Artandi, S. E. (2009) · Science · doi:10.1126/science.1165357 · Cited by 522 · cited 1×
“Autosomal recessive mutations in TCAB1 cause mislocalization of telomerase to nucleoli (Venteicher et al. 2009; Zhong et al. 2011, 2012).”
BackgroundSelf-citationSuper-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation
Doksani, Y., Wu, J. Y., de Lange, T., & Zhuang, X. (2013) · Cell · doi:10.1016/j.cell.2013.09.048 · Cited by 493 · cited 1×
“The single-stranded overhang can fold back on the double-stranded telomere in a lariat structure termed the T-loop, which serves to sequester the chromosome terminus, which hybridizes to internal sequences creating a small displacement loop, or D-loop (Griffith et al. 1999; Doksani et al. 2013).”
BackgroundGenome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484 · cited 2×
“…83% of primary glioblastomas, 66% of urothelial carcinomas of the bladder, 47% of hepatocellular carcinomas, and 71% of melanomas, making these mutations the most common noncoding mutation in cancer discovered thus far (Killela et al. 2013; Kinde et al. 2013; Weinhold et al. 2014).”
BackgroundCancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
Herrera, E., Samper, E., Martín‐Caballero, J., Flores, J. M., Lee, H., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.2950 · Cited by 471 · cited 2×
“Telomere shortening in G6 TERC p53þ/þ mice precipitated a premature aging phenotype, characterized by kyphosis, hair graying, hair loss, villous atrophy in the intestine, and impaired systemic stress responses (Herrera et al. 1999; Rudolph et al. 1999).”
BackgroundStuart, B. D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., Dharwadkar, P., Torres, F., Girod, C. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3278 · Cited by 469 · cited 2×
“…Harb Perspect Med 2017;7:a026088 11 w w w .p er sp ec ti ve si n m ed ic in e. o rg a nuclease that removes polyA sequences from RNAs, have been reported to cause severe DC and IPF, by promoting TERC species with increased polyA tails (Dhanraj et al. 2015; Moon et al. 2015; Stuart et al. 2015).”
BackgroundVulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I. (2004) · Nature Genetics · doi:10.1038/ng1346 · Cited by 461 · cited 1×
“DC can become more severe and present at an earlier age in the children of patients as telomeres shorten from generation to generation, just as in telomerase knockout mice (Vulliamy et al. 2004; Armanios et al. 2005).”
BackgroundYe, J. Z.-S., Hockemeyer, D., Krutchinsky, A. N., Loayza, D., Hooper, S. M., Chait, B. T., & de Lange, T. (2004) · Genes & Development · doi:10.1101/gad.1215404 · Cited by 459
Armanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452 · cited 3×
“…TERC accumulation; decreased telomerase activity Mitchell et al. 1999 Autosomal dominant TERT Catalytic subunit Decreased telomerase activity Armanios et al. 2005; Yamaguchi et al. 2005 TERC RNA template subunit Decreased telomerase activity Vulliamy et al. 2001 TINF2 Shelterin protein…”
BackgroundPTOP interacts with POT1 and regulates its localization to telomeres
Liu, D., Safari, A., O'Connor, M. S., Chan, D. W., Laegeler, A., Qin, J., & Songyang, Z. (2004) · Nature Cell Biology · doi:10.1038/ncb1142 · Cited by 450
Wu, L., Multani, A. S., He, H., Cosme-Blanco, W., Deng, Y., Deng, J. M., Bachilo, O., Pathak, S., Tahara, H., Bailey, S. M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.037 · Cited by 422
Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 3×
“Mutations in TIN2 occur in a severe autosomal-dominant form of the disease that acts through as-yet unclear mechanisms (Savage et al. 2008).”
BackgroundShort Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A. (2000) · Nature Genetics · doi:10.1038/79089 · Cited by 347 · cited 2×
“In this model, treatment of G5 TERC2/2 mice with DMBA/TPA led to a 20-fold lower rate of papilloma development than in WT mice and a 16-fold lower rate than in G1 TERC 2/2 animals, suggesting that, in this context, short telomeres are protective against carcinogenesis (Gonzalez-Suarez et al. 2000).”
Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., & Dokal, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800042105 · Cited by 334 · cited 2×
“…et al. 2008 Autosomal recessive NHP2, NOP10 TERC biogenesis Decreased TERC accumulation; decreased telomerase activity Walne et al. 2007; Vulliamy et al. 2008 TCAB1 Telomerase trafficking Decreased telomerase recruitment Zhong et al. 2011 CTC1 Telomere protection Telomere uncapping…”
BackgroundWalne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm111 · Cited by 316 · cited 2×
“…telomere shortening Savage et al. 2008 Autosomal recessive NHP2, NOP10 TERC biogenesis Decreased TERC accumulation; decreased telomerase activity Walne et al. 2007; Vulliamy et al. 2008 TCAB1 Telomerase trafficking Decreased telomerase recruitment Zhong et al. 2011 CTC1 Telomere protection…”
BackgroundHockemeyer, D., Sfeir, A. J., Shay, J. W., Wright, W. E., & de Lange, T. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600733 · Cited by 314 · cited 1×
“POT1 and TPP1 serve a role in protecting the single-stranded portion of the telomere, because loss of POT1 impairs telomere capping (Hockemeyer et al. 2005, 2006; Wu et al. 2006; Hockemeyer et al. 2007).”
BackgroundTelomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation
Wong, K.-K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., et al. (2000) · Nature Genetics · doi:10.1038/79232 · Cited by 309
Self-citationMutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Yamaguchi, H., Baerlocher, G. M., Lansdorp, P. M., Chanock, S. J., Nunez, O., Sloand, E., & Young, N. S. (2003) · Blood · doi:10.1182/blood-2003-01-0335 · Cited by 301 · cited 1×
“Five percent to 10% of aplastic anemia is also caused by telomerase mutations (Yamaguchi et al. 2003, 2005).”
BackgroundPersistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Davoli, T., Denchi, E. L., & de Lange, T. (2010) · Cell · doi:10.1016/j.cell.2010.01.031 · Cited by 298
TERT promoter mutations and telomerase reactivation in urothelial cancer
Borah, S., Xi, L., Zaug, A. J., Powell, N. M., Dancik, G. M., Cohen, S. B., Costello, J. C., Theodorescu, D., & Cech, T. R. (2015) · Science · doi:10.1126/science.1260200 · Cited by 292
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development · doi:10.1101/gad.2006411 · Cited by 262
Self-citationKinde, I., Munari, E., Faraj, S. F., Hruban, R. H., Schoenberg, M., Bivalacqua, T., Allaf, M., Springer, S., Wang, Y., Diaz, L. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2498 · Cited by 253 · cited 1×
“…83% of primary glioblastomas, 66% of urothelial carcinomas of the bladder, 47% of hepatocellular carcinomas, and 71% of melanomas, making these mutations the most common noncoding mutation in cancer discovered thus far (Killela et al. 2013; Kinde et al. 2013; Weinhold et al. 2014).”
BackgroundTelomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
Self-citationDavoli, T., & de Lange, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.044 · Cited by 242
A Platform for Rapid Exploration of Aging and Diseases in a Naturally Short-Lived Vertebrate
Harel, I., Benayoun, B. A., Machado, B., Singh, P. P., Hu, C.-K., Pech, M. F., Valenzano, D. R., Zhang, E., Sharp, S. C., Artandi, S. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.038 · Cited by 232
Self-citationTelomerase gene mutations are associated with cirrhosis formation
Hartmann, D., Srivastava, U., Thaler, M., Kleinhans, K. N., N'Kontchou, G., Scheffold, A., Bauer, K., Kratzer, R. F., Kloos, N., Katz, S.-F., et al. (2011) · Hepatology · doi:10.1002/hep.24217 · Cited by 173
The Telomere Deprotection Response Is Functionally Distinct from the Genomic DNA Damage Response
Cesare, A. J., Hayashi, M. T., Crabbe, L., & Karlseder, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.006 · Cited by 155 · cited 2×
“…or in cell cultures with partially depleted TRF2 results in a differential double-stranded break response without phosphorylation of Chk2 and induction of the G2/M checkpoint; damaged telomeres are allowed to pass through mitosis and cause G1 growth arrest in daughter cells (Cesare et al. 2013).”
BackgroundTelomerase Is Required for Zebrafish Lifespan
Henriques, C. M., Carneiro, M. C., Tenente, I. M., Jacinto, A., & Ferreira, M. G. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003214 · Cited by 133 · cited 1×
“Because of their shorter telomeres, zebrafish lacking the telomerase catalytic subunit TERT exhibit shorter life spans within the first generation and show infertility, intestinal atrophy, and loss of skeletal muscle (Henriques et al. 2013).”
BackgroundKeegan, C. E., Hutz, J. E., Else, T., Adamska, M., Shah, S. P., Kent, A. E., Howes, J. M., Beamer, W. G., & Hammer, G. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi011 · Cited by 68
Else, T., Trovato, A., Kim, A. C., Wu, Y., Ferguson, D. O., Kuick, R. D., Lucas, P. C., & Hammer, G. D. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.011 · Cited by 62
Khoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52 · cited 2×
“G5 TERC mice lacking exon 2 of the locus developed tumors at half the rate of controls (Greenberg et al. 1999; Khoo et al. 2007).”
BackgroundVlangos, C. N., O'Connor, B. C., Morley, M. J., Krause, A. S., Osawa, G. A., & Keegan, C. E. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.07.038 · Cited by 29
Cited by
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
The p53 network: cellular and systemic DNA damage responses in cancer and aging
Vaddavalli, P. L., & Schumacher, B. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.010 · Cited by 279
Zhu, Y., Liu, X., Ding, X., Wang, F., & Geng, X. (2019) · Biogerontology · doi:10.1007/s10522-018-9769-1 · Cited by 255
The anti-aging mechanism of ginsenosides with medicine and food homology
Tian, T., Ko, C.-N., Luo, W., Li, D., & Yang, C. (2023) · Food & Function · doi:10.1039/d3fo02580b · Cited by 62
Vodicka, P., Andera, L., Opattova, A., & Vodickova, L. (2021) · Cancers · doi:10.3390/cancers13030479 · Cited by 39
Metadata
- Authors
- Roake, C. M., & Artandi, S. E.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-03-13
- Volume
- 7
- Issue
- 5
- Pages
- a026088
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2595332769
- Cited by
- 67
- References
- 72
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.